Status:
RECRUITING
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
Lead Sponsor:
LCMC Health
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy...
Detailed Description
Preclinical studies support that HBOT augments several adaptive mechanisms following ischemic stroke, including neuroplasticity, cerebral angiogenesis, and regeneration of nerve fibers. The earlier th...
Eligibility Criteria
Inclusion
- Age 18 years and above
- Ischemic stroke proven on neuroimaging
- Within 7-30 days post-stroke on day 1 of treatment
- Admitted to Touro Inpatient Rehab Facility
Exclusion
- Pre-stroke modified Rankin Scale Score \>2
- Parenchymal hemorrhagic transformation (PH1 or PH2)
- Receptive aphasia such that recommendations for preventative measures to mitigate barotrauma cannot be followed
- History of recurrent and unprovoked seizures requiring a change in management in the last 3 months to control seizures
- Pulmonary disease requiring supplemental oxygen or daily respiratory medication management (metered dose inhalers, nebulized treatment or steroids)
Key Trial Info
Start Date :
May 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06148285
Start Date
May 24 2022
End Date
December 31 2026
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Touro Infirmary New Orleans
New Orleans, Louisiana, United States, 70112